Frank Karbe, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 12,500 shares at $7.93 ($99K) on 2024-12-13, disclosed to the SEC on 2024-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BTTX | BUY | 2022-09-15 | $105K | — | Filing → |
| MYOV | SELL | 2021-07-09 | $70K | — | Filing → |
| MYOV | SELL | 2021-04-08 | $413K | — | Filing → |